Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Ultragenyx Pharmaceutical Inc. is a biopharmaceutical company committed to bringing to patients novel products for the treatment of serious rare and ultra-rare genetic diseases. The company has a diverse portfolio of approved therapies and product candidates aimed at addressing diseases with high unmet medical need, where biology is well understood, and for which there are no approved therapies. Ultragenyx focuses on withdrawing from the natural history of these devastating diseases to make a meaningful difference for patients and their families. Their approach involves identifying, acquiring, developing, and commercializing innovative therapies, often leveraging advanced scientific understanding of disease pathways.
The Novato headquarters serves as the central hub for Ultragenyx's global operations, including executive leadership, research and development strategy, corporate administration, and coordination of global commercial and clinical activities.
The headquarters likely features modern laboratory spaces for research, collaborative office environments designed to foster innovation, and facilities to support its growing global team. Specific architectural details are not widely publicized, but biotech HQs in this region are typically state-of-the-art.
Ultragenyx fosters a science-driven, patient-focused work culture. Employees are often motivated by the direct impact their work has on individuals with rare diseases. The culture emphasizes collaboration, urgency, integrity, and innovation.
The Novato headquarters is strategically important for Ultragenyx's mission, providing a base for its pioneering research into rare diseases and a central point for managing its expanding pipeline and commercial products worldwide.
Ultragenyx Pharmaceutical Inc. has a growing global presence, with key operations focused in North America (USA and Canada), Europe (centered in Switzerland), and Latin America (with a hub in Brazil). Their functions supported globally include clinical trial management across numerous countries, regulatory submissions to health authorities worldwide, manufacturing and supply chain logistics for their therapies, and commercialization efforts to ensure patient access to their medicines in approved markets.
60 Leveroni Court
Novato
California
USA
Address: Address not publicly specified for all operational sites, generally in biotech park areas.
Serves as a key R&D and operational site in the San Francisco Bay Area, leveraging the local biotech talent pool and infrastructure.
Address: Viertelkreis 3, 4104 Oberwil (Basel-Landschaft)
To manage and expand Ultragenyx's presence in Europe, ensuring patient access to its therapies and navigating the European regulatory landscape.
Address: Gene Therapy Development and Manufacturing Facility (specific address not widely publicized for operational security)
Leverages the strong biotech ecosystem in the Cambridge/Boston area, particularly for specialized areas like gene therapy manufacturing and research.
Address: Specific office address within Sao Paulo.
To establish and grow Ultragenyx's footprint in Latin America, bringing therapies for rare diseases to patients in these countries.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Ultragenyx' leadership includes:
Ultragenyx has been backed by several prominent investors over the years, including:
In the past 12 months, Ultragenyx saw a key transition in its finance leadership with the retirement of its long-standing CFO and the appointment of a new Chief Financial Officer.
Discover the tools Ultragenyx uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Ultragenyx Pharmaceutical Inc. commonly uses the first initial followed by the last name for its employee email addresses. This is a standard format for many corporations.
[first_initial][last]@ultragenyx.com
Format
ekakkis@ultragenyx.com
Example
85%
Success rate
GlobeNewswire • May 7, 2024
Ultragenyx announced its first-quarter 2024 financial results, highlighting revenue growth from its commercial products Crysvita®, Dojolvi®, and Evkeeza®. The company also provided updates on its clinical pipeline, including progress in gene therapy programs for Osteogenesis Imperfecta and Wilson Disease....more
GlobeNewswire • April 2, 2024
Ultragenyx announced that interim data from the Phase 3 Orbit study of setrusumab in pediatric and adolescent patients with OI showed a statistically significant reduction in fracture rate. The data will be presented at the European Congress of Endocrinology (ECE) 2024....more
GlobeNewswire • February 21, 2024
Ultragenyx reported its financial results for the fourth quarter and full year 2023, detailing strong revenue performance and advancements across its clinical development programs. The company emphasized its transition towards becoming a profitable rare disease leader....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Ultragenyx, are just a search away.